Business Development

"Our goal is to bring first or second to market generic products for both the hospital and retail setting"
Jeff Skinner, Vice President, Business Development

VPI Pharmaceuticals has built an extensive global network of contacts and partners allowing us to seek out the opportunities that meet our objectives in bringing products to the market in Canada. With experience in the development of products (and dossiers), in-licensing and acquisition of products, and the launch of products, we have developed an expertise in providing solutions to the generic products market.

While the decision is always driven by the market demand for products, our primary areas of expertise and focus include:

  • Hospital (injectable) products
  • Niche oral solid dose products
  • First or second to market generics
  • Difficult to produce (or source) products

Get in Touch

If you are interested in potential business opportunities, please contact

Pete Ecclestone – Vice President, Business Development
pete.ecclestone@valeopharma.com